ARS Pharmaceuticals (SPRY) Company Overview

Profile

Full Name:

ARS Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 4, 2020

Indexes:

Not included

Description:

SPRY (ARS Pharmaceuticals) focuses on developing innovative treatments for respiratory conditions. Their main product is a nasal spray for emergency allergic reactions, providing a quick and effective solution. The company aims to improve patient care and accessibility to life-saving medications.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 14, 25 Raymond James
Strong Buy
Jan 13, 25 Leerink Partners
Outperform
Oct 8, 24 Cantor Fitzgerald
Overweight
Sep 20, 24 Leerink Partners
Outperform
Sep 16, 24 Cantor Fitzgerald
Overweight
Sep 9, 24 Cantor Fitzgerald
Overweight
Aug 20, 24 Cantor Fitzgerald
Overweight
Aug 13, 24 Raymond James
Strong Buy
Jul 25, 24 Raymond James
Outperform
Mar 11, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ARS Pharmaceuticals?
  • Does ARS Pharmaceuticals pay dividends?
  • What sector is ARS Pharmaceuticals in?
  • What industry is ARS Pharmaceuticals in?
  • What country is ARS Pharmaceuticals based in?
  • When did ARS Pharmaceuticals go public?
  • Is ARS Pharmaceuticals in the S&P 500?
  • Is ARS Pharmaceuticals in the NASDAQ 100?
  • Is ARS Pharmaceuticals in the Dow Jones?
  • When was ARS Pharmaceuticals's last earnings report?
  • When does ARS Pharmaceuticals report earnings?
  • Should I buy ARS Pharmaceuticals stock now?

What is the ticker symbol for ARS Pharmaceuticals?

The ticker symbol for ARS Pharmaceuticals is NASDAQ:SPRY

Does ARS Pharmaceuticals pay dividends?

No, ARS Pharmaceuticals does not pay dividends

What sector is ARS Pharmaceuticals in?

ARS Pharmaceuticals is in the Healthcare sector

What industry is ARS Pharmaceuticals in?

ARS Pharmaceuticals is in the Biotechnology industry

What country is ARS Pharmaceuticals based in?

ARS Pharmaceuticals is headquartered in United States

When did ARS Pharmaceuticals go public?

ARS Pharmaceuticals's initial public offering (IPO) was on December 4, 2020

Is ARS Pharmaceuticals in the S&P 500?

No, ARS Pharmaceuticals is not included in the S&P 500 index

Is ARS Pharmaceuticals in the NASDAQ 100?

No, ARS Pharmaceuticals is not included in the NASDAQ 100 index

Is ARS Pharmaceuticals in the Dow Jones?

No, ARS Pharmaceuticals is not included in the Dow Jones index

When was ARS Pharmaceuticals's last earnings report?

ARS Pharmaceuticals's most recent earnings report was on Nov 13, 2024

When does ARS Pharmaceuticals report earnings?

The next expected earnings date for ARS Pharmaceuticals is Mar 21, 2025

Should I buy ARS Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions